VaxSyna, inc. is a pre-clinical vaccine company that is creating room-temperature stable vaccines using a patented antibody-protein conjugate platform. This platform is highly effective in pre-clinical animal models. Currently VaxSyna is pursuing a pan-protective HPV vaccine to prevent 100% of HPV associated cancers which account for 5% of all cancers globally.
Speaker
